Allergan had a good third quarter, with sales up by...

Allergan had a good third quarter, with sales up by 10.5 percent to $1,098.2 million over the same period last year. That represents an increase of 8.6 percent at constant currencies. In eye care pharmaceuticals, revenues grew by 11.5 percent to $510.4 million, or 9.1 percent at constant currencies. The ...

Keep reading this article by becoming a member

barrier_image_OIC

Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.